Delivering mitochondrial health
This fall, Abliva's CEO, Ellen Donnelly will attend the two connected events LSX Inv€$tival Showcase and Jefferies London Healthcare Conference. On November 13 at 11:45 a.m., the Abliva's CEO, Ellen […]
In late November, Abliva will attend Nordic Life Science Days, at Bella Center in Copenhagen, Denmark. CEO Ellen Donnelly will be presenting the company during the session Biotechnology - Therapeutics […]
In early January 2024, Abliva's CEO, Ellen Donnelly, will attend the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco, USA. The conference is a healthcare investment symposium that connects […]
In mid-April, Abliva will participate at Kempen Life Sciences Conference in Amsterdam, The Netherlands. For more information, please click the link below.
In mid-May, Abliva will travel to the Bio€quity Europe meeting in San Sebastán, Spain. "For more than 20 years, Bio€quity Europe has been where CEOs and investors gather to network, […]
Join Abliva for a virtual KOL event featuring Amel Karaa, MD (Massachusetts General Hospital), who will discuss the unmet medical need and current treatment landscape for patients with primary mitochondrial […]
In early November, Abliva's CEO, Ellen Donnelly, will attend the BIO-Europe meeting in Stockholm, Sweden. On Monday, November 4, Ellen will be presenting the company at 4:30 p.m. CET. Follow […]
